Human Immunodeficiency Virus (HIV) Diagnosis Market Report 2026

Human Immunodeficiency Virus (HIV) Diagnosis Market Overview

• Human Immunodeficiency Virus (HIV) Diagnosis market size has reached to $4.67 billion in 2025 • Expected to grow to $7.4 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Blood Donation On The HIV Diagnosis Market • Market Trend: Long-Acting Injectable Prevention Breakthroughs Transforming HIV Care Accessibility And Adherence Worldwide • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Immunodeficiency Virus (HIV) Diagnosis Market?

Human immunodeficiency viruses (HIV) diagnosis refers to the process of determining whether an individual has been infected with the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome. This diagnosis involves testing for the presence of HIV antibodies, antigens, or viral genetic material in a person's blood, saliva, or other bodily fluids. The main products of human immunodeficiency virus (HIV) diagnosis are consumables, instruments, and software and services. Consumables refer to materials, supplies, or items that are consumed or used up in the course of performing a task, process, or activity. They can be administered as various modes including self-test and lab-based. They are used by different end users including diagnostic laboratories, hospitals, and research institutions.

What Is The Human Immunodeficiency Virus (HIV) Diagnosis Market Growth Forecast?

The human immunodeficiency virus (hiv) diagnosis market size is expected to see strong growth in the next few years. It will grow to $7.4 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for early hiv detection, increasing adoption of self-test kits, expansion of point-of-care diagnostic technologies, growing focus on hiv prevention and monitoring, increasing investments in infectious disease diagnostics. Major trends in the forecast period include increasing adoption of rapid and point-of-care hiv testing, growing emphasis on early and routine hiv screening, rising demand for self-testing and home-based diagnostics, expansion of integrated hiv testing and counseling services, increasing focus on data-driven hiv surveillance and reporting.

Global Human Immunodeficiency Virus (HIV) Diagnosis Market Segmentation

1) By Product: Consumables, Instruments, Software, Services 2) By Mode: Self-Test, Lab-Based 3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions Subsegments: 1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits), Reagents And Chemicals, Sample Collection Devices (Blood Collection Tubes, Lancets), Test Strips, Control And Calibration Kits, Disposable Gloves And Safety Equipment 2) By Instruments: Hiv Diagnostic Analyzers ( Immunoassay-analyzers-global-market-report" target="_blank">Automated Immunoassay Analyzers), Hiv Viral Load Testing Equipment, Cd4 Count Analyzers, Point-Of-Care Hiv Diagnostic Devices, Molecular Diagnostic Instruments ( Pcr Machines), Electrochemical And Optical Hiv Detection Instruments 3) By Software: Hiv Diagnosis Data Management Software, Electronic Health Record (Ehr) Integration Software, Hiv Test Result Interpretation Software, Laboratory Information Management Systems (Lims), Patient Monitoring And Tracking Software, Cloud-Based Hiv Diagnostic Reporting Tools 4) By Services: Diagnostic Testing Services, Hiv Testing Support Services ( Counseling, Education), Diagnostic Lab Services, Telemedicine And Remote Hiv Testing Services, Clinical Trial Services For Hiv Diagnostic Tests, Data Analytics And Interpretation Services For Hiv Testing

What Is The Driver Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?

The rising blood donation is expected to propel the growth of the HIV diagnosis market going forward. Blood donation refers to the voluntary act of giving blood through phlebotomy, where a needle is inserted into a vein to collect blood. The rise in blood donation combines advancements in medical technology, community engagement, and improved donor recruitment and retention strategies. With more people donating blood, a larger pool of samples is available for HIV testing. This increased availability of blood samples allows for more comprehensive screening for HIV antibodies or antigens, improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, rising blood donation is driving the growth of the HIV diagnosis market.

Key Players In The Global Human Immunodeficiency Virus (HIV) Diagnosis Market

Major companies operating in the human immunodeficiency virus (hiv) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Molecular Diagnostics, Atila BioSystems Inc.

Global Human Immunodeficiency Virus (HIV) Diagnosis Market Trends and Insights

Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are focusing on developing long-acting, highly effective prevention and treatment options, expanding access through supportive reimbursement programs, and advancing innovative clinical strategies to improve adherence and reduce new HIV infections. For instance, in June 2025, Gilead Sciences, a US-based healthcare company, received FDA approval for Yeztugo (lenacapavir), the first and only twice-yearly injectable PrEP option, marking a major advancement in HIV prevention. Backed by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug showed exceptional efficacy, with ≥99.9% of participants remaining HIV-negative. The long-acting injection aims to overcome barriers such as adherence challenges, stigma, and low awareness that limit current PrEP use. Yeztugo’s approval offers a promising tool to help reduce new HIV infections across diverse populations. Gilead is also implementing broad access measures, including insurance partnerships, co-pay support for eligible patients, and free access for uninsured individuals through assistance programs.

What Are Latest Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market?

In July 2025, Future Pak, a US-based contract development and manufacturing organization (CDMO), acquired Theratechnologies Inc. for up to $254 million. With this acquisition, Future Pak aims to deepen its position in the HIV therapeutics market by integrating Theratechnologies’ marketed HIV drugs including Trogarzo and Egrifta and leveraging their expertise in commercialization to drive further growth. Theratechnologies, headquartered in Canada, is a biopharmaceutical company known for its HIV focused product portfolio, including its monoclonal antibody Trogarzo (ibalizumab) and HIV-associated lipodystrophy treatment Egrifta (tesamorelin)

Regional Outlook

North America was the largest region in the HIV diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Immunodeficiency Virus (HIV) Diagnosis Market?

The human immunodeficiency virus (HIV) diagnosis market consists of revenues earned by entities by providing services such as HIV testing, pre-test counseling, post-test counseling, laboratory-based testing, point-of-care testing, partner notification services, and linkage to care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human immunodeficiency virus (HIV) diagnosis market also includes sales of diagnostic kits, testing equipment such as enzyme-linked immunosorbent assay (ELISA) readers and polymerase chain reaction (PCR) machines, point-of-care testing devices, laboratory equipment like centrifuges and microscopes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Immunodeficiency Virus (HIV) Diagnosis Market Report 2026?

The human immunodeficiency virus (hiv) diagnosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human immunodeficiency virus (hiv) diagnosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.